With 3-year commercialization paths for synaptic vesicle recycling therapeutics
synaptic vesicles
neurodegeneration
drug development
commercialization
neuroscience
Optimizing gut-brain axis modulation using precision probiotic strains and neural biomarkers
gut-brain axis
probiotics
neurotransmitters
microbiome
neural biomarkers
Microbiome rejuvenation through CRISPR-based phage therapy targeting antibiotic-resistant pathogens
microbiome
CRISPR
phage therapy
antibiotic resistance
gut health
For immediate pandemic response using CRISPR-based viral detection systems
CRISPR diagnostics
viral detection
pandemic response
point-of-care testing
RNA targeting
Combining ancient and modern methods to revive lost medicinal compounds
ethnopharmacology
drug discovery
AI chemistry
traditional medicine
bioactive compounds
Designing solvent selection engines for sustainable pharmaceutical manufacturing
solvent selection
green chemistry
pharmaceutical manufacturing
AI optimization
sustainability
Developing continuous flow chemistry systems for scalable senolytic drug discovery
flow chemistry
senolytics
drug discovery
automation
aging research
Enhancing drug discovery via multimodal fusion architectures for molecular property prediction
drug discovery
multimodal fusion
machine learning
cheminformatics
bioactivity
Targeting 2025 regulatory approval for CRISPR-based neurodegenerative therapies
CRISPR
neurodegenerative diseases
regulatory approval
gene therapy
clinical trials
Enhancing tumor detection by integrating neutrino physics with medical imaging
neutrino imaging
medical diagnostics
tumor detection
particle physics
oncology
Optimizing protein folding intermediates through solvent selection engines for enhanced stability
protein folding
solvent selection
biopharmaceuticals
computational optimization
intermediate states
With flow chemistry robots to accelerate drug discovery pipelines
flow chemistry
drug discovery
robotic automation
synthetic biology
high-throughput screening